Ingevity Corporation Reports $59.8 Million Net Income in Q1 2026, Driven by Strategic Divestitures

Ingevity Corporation reported a net income of $59.8 million for the first quarter of 2026, a significant increase from the $20.5 million recorded in the same period last year. The company’s net sales reached $258.0 million, reflecting a 4% increase compared to $247.9 million in the first quarter of 2025. This growth was primarily driven by price increases in the Performance Materials segment and favorable foreign exchange rates. The gross profit for the quarter was $116.4 million, up from $111.9 million a year earlier, while the company’s operating expenses, including selling, general, and administrative expenses, totaled $40.7 million.

Ingevity's financial performance showed notable improvements in several areas compared to the previous fiscal period. The company’s income from continuing operations before income taxes was $30.2 million, compared to $37.6 million in the prior year. The effective tax rate remained stable at approximately 22.5%. The increase in net income was bolstered by a gain of $55.6 million from the sale of its industrial specialties product line, which was classified as discontinued operations. This divestiture, completed on January 1, 2026, allowed Ingevity to streamline its operations and focus on its core segments.

Strategically, Ingevity has made significant moves, including the divestiture of its industrial specialties product line and the completion of a sale of its road markings product line to PPG Industries for $65 million, which is expected to close in mid-April 2026. The company has also restructured its operations to enhance efficiency, with a focus on its Performance Materials, Performance Chemicals, and Advanced Polymer Technologies segments. The Performance Materials segment reported net sales of $155.4 million, a 6% increase from the previous year, while the Performance Chemicals segment remained stable at $58.3 million.

Operationally, Ingevity's total assets as of March 31, 2026, were $1.65 billion, slightly down from $1.65 billion at the end of 2025. The company’s cash and cash equivalents increased to $95.4 million, up from $78.1 million at the end of the previous year. The employee headcount remained stable, and the company reported a net cash outflow from operating activities of $2.0 million, primarily due to increased working capital requirements. Looking ahead, Ingevity expects net sales for 2026 to be between $1.05 billion and $1.15 billion, with adjusted EBITDA projected between $370 million and $395 million, as it continues to navigate market conditions and capitalize on growth opportunities in its core segments.